These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 17681547)
21. Fish, docosahexaenoic acid and Alzheimer's disease. Cunnane SC; Plourde M; Pifferi F; Bégin M; Féart C; Barberger-Gateau P Prog Lipid Res; 2009 Sep; 48(5):239-56. PubMed ID: 19362576 [TBL] [Abstract][Full Text] [Related]
22. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Song MS; Rauw G; Baker GB; Kar S Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381 [TBL] [Abstract][Full Text] [Related]
23. Mechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cells. Hossain S; Hashimoto M; Katakura M; Miwa K; Shimada T; Shido O J Neurochem; 2009 Oct; 111(2):568-79. PubMed ID: 19686246 [TBL] [Abstract][Full Text] [Related]
24. Protective effect of Z-ligustilide against amyloid beta-induced neurotoxicity is associated with decreased pro-inflammatory markers in rat brains. Kuang X; Du JR; Chen YS; Wang J; Wang YN Pharmacol Biochem Behav; 2009 Jun; 92(4):635-41. PubMed ID: 19324070 [TBL] [Abstract][Full Text] [Related]
25. Immune blood biomarkers of Alzheimer disease patients. Avagyan H; Goldenson B; Tse E; Masoumi A; Porter V; Wiedau-Pazos M; Sayre J; Ong R; Mahanian M; Koo P; Bae S; Micic M; Liu PT; Rosenthal MJ; Fiala M J Neuroimmunol; 2009 May; 210(1-2):67-72. PubMed ID: 19329192 [TBL] [Abstract][Full Text] [Related]
26. Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats. Arancibia S; Silhol M; Moulière F; Meffre J; Höllinger I; Maurice T; Tapia-Arancibia L Neurobiol Dis; 2008 Sep; 31(3):316-26. PubMed ID: 18585459 [TBL] [Abstract][Full Text] [Related]
27. The emerging role of docosahexaenoic acid in neuroinflammation. Orr SK; Bazinet RP Curr Opin Investig Drugs; 2008 Jul; 9(7):735-43. PubMed ID: 18600579 [TBL] [Abstract][Full Text] [Related]
28. Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes. Shieh PC; Tsao CW; Li JS; Wu HT; Wen YJ; Kou DH; Cheng JT Neurosci Lett; 2008 Mar; 434(1):1-5. PubMed ID: 18313848 [TBL] [Abstract][Full Text] [Related]
29. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E. Fan J; Donkin J; Wellington C Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365 [TBL] [Abstract][Full Text] [Related]
30. Melatonin prevents amyloid protofibrillar induced oxidative imbalance and biogenic amine catabolism. Gunasingh MJ; Philip JE; Ashok BS; Kirubagaran R; Jebaraj WC; Davis GD; Vignesh S; Dhandayuthapani S; Jayakumar R Life Sci; 2008 Jul; 83(3-4):96-102. PubMed ID: 18590917 [TBL] [Abstract][Full Text] [Related]
31. Amyloid beta peptides and glutamatergic synaptic dysregulation. Parameshwaran K; Dhanasekaran M; Suppiramaniam V Exp Neurol; 2008 Mar; 210(1):7-13. PubMed ID: 18053990 [TBL] [Abstract][Full Text] [Related]
32. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Maczurek A; Hager K; Kenklies M; Sharman M; Martins R; Engel J; Carlson DA; Münch G Adv Drug Deliv Rev; 2008; 60(13-14):1463-70. PubMed ID: 18655815 [TBL] [Abstract][Full Text] [Related]
33. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers. Meli G; Visintin M; Cannistraci I; Cattaneo A J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429 [TBL] [Abstract][Full Text] [Related]
34. Docosahexaenoic acid-induced protective effect against impaired learning in amyloid beta-infused rats is associated with increased synaptosomal membrane fluidity. Hashimoto M; Hossain S; Shimada T; Shido O Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):934-9. PubMed ID: 17002670 [TBL] [Abstract][Full Text] [Related]
35. Synaptic degeneration in Alzheimer's disease. Arendt T Acta Neuropathol; 2009 Jul; 118(1):167-79. PubMed ID: 19390859 [TBL] [Abstract][Full Text] [Related]
36. Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo. Hu NW; Smith IM; Walsh DM; Rowan MJ Brain; 2008 Sep; 131(Pt 9):2414-24. PubMed ID: 18678563 [TBL] [Abstract][Full Text] [Related]
37. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372 [TBL] [Abstract][Full Text] [Related]
38. Why docosahexaenoic acid and aspirin supplementation could be useful in women as a primary prevention therapy against Alzheimer's disease? Pomponi MF; Gambassi G; Pomponi M; Di Gioia A; Masullo C Ageing Res Rev; 2011 Jan; 10(1):124-31. PubMed ID: 20920611 [TBL] [Abstract][Full Text] [Related]